Elevance Health Reaffirms FY2026 EPS Guidance at Least $19.85

Elevance Health, Inc. officers expect to speak with investors and analysts this week, reaffirming the company's full-year 2026 shareholders' earnings guidance. The company expects at least $19.85 per diluted share, including approximately $6.90 per diluted share of net unfavorable items. Excluding these items, adjusted shareholders' earnings are anticipated to be at least $26.75 per diluted share. Additionally, the full-year 2026 benefit expense ratio guidance of 90.2% plus or minus 50 basis points was reaffirmed.